A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy
出版年份 2022 全文链接
标题
A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy
作者
关键词
-
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 353, Issue -, Pages 535-548
出版商
Elsevier BV
发表日期
2022-12-10
DOI
10.1016/j.jconrel.2022.12.001
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
- (2022) Lanxiang Huang et al. Molecular Cancer
- Development of a Localized Drug Delivery System with a Step-by-Step Cell Internalization Capacity for Cancer Immunotherapy
- (2022) Xilin Li et al. ACS Nano
- Antisense vicR-Loaded Dendritic Mesoporous Silica Nanoparticles Regulate the Biofilm Organization and Cariogenicity of Streptococcus mutans
- (2022) Yuting Tian et al. International Journal of Nanomedicine
- ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines
- (2022) Xu Liu et al. ACS Nano
- Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple‐Negative Breast Cancer
- (2022) Zitong Zhao et al. ADVANCED MATERIALS
- Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy
- (2021) Xiang Xiong et al. NANO LETTERS
- Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy
- (2021) Xiang Xiong et al. Nano Today
- Therapeutic targeting of the hypoxic tumour microenvironment
- (2021) Dean C. Singleton et al. Nature Reviews Clinical Oncology
- A Redox‐Responsive Nanovaccine Combined with A2A Receptor Antagonist for Cancer Immunotherapy
- (2021) Peng Yan et al. Advanced Healthcare Materials
- A pH-responsive polymersome depleting regulatory T cells and blocking A2A receptor for cancer immunotherapy
- (2021) Binfen Shao et al. Nano Research
- Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
- (2021) Bram Van Den Eeckhout et al. Journal for ImmunoTherapy of Cancer
- Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC).
- (2020) Lauren Christine Harshman et al. JOURNAL OF CLINICAL ONCOLOGY
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Moving Immune Therapy Forward Targeting TME
- (2020) Kayla F Goliwas et al. PHYSIOLOGICAL REVIEWS
- Cancer immunotherapy comes of age and looks for maturity
- (2020) Amanda Finck et al. Nature Communications
- Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
- (2020) Stephen M. Hatfield et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies.
- (2019) John D. Powderly et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
- (2019) Qiuhua Luo et al. CANCER LETTERS
- Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator
- (2019) Ruolin Lu et al. JOURNAL OF CONTROLLED RELEASE
- Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy
- (2019) Wei Zhang et al. ACS Applied Materials & Interfaces
- Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
- (2019) Lawrence Fong et al. Cancer Discovery
- Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy
- (2018) Xingshu Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
- (2018) Alberto Chiappori et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses
- (2018) Lutz Nuhn et al. ADVANCED MATERIALS
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy
- (2016) Guosheng Song et al. ADVANCED MATERIALS
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Innate immune signaling and regulation in cancer immunotherapy
- (2016) Leticia Corrales et al. CELL RESEARCH
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
- (2014) P. Chaturvedi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More